1. Home
  2. ADMA vs CVCO Comparison

ADMA vs CVCO Comparison

Compare ADMA & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • CVCO
  • Stock Information
  • Founded
  • ADMA 2004
  • CVCO 1965
  • Country
  • ADMA United States
  • CVCO United States
  • Employees
  • ADMA N/A
  • CVCO N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • CVCO Homebuilding
  • Sector
  • ADMA Health Care
  • CVCO Consumer Discretionary
  • Exchange
  • ADMA Nasdaq
  • CVCO Nasdaq
  • Market Cap
  • ADMA 5.1B
  • CVCO 4.3B
  • IPO Year
  • ADMA N/A
  • CVCO N/A
  • Fundamental
  • Price
  • ADMA $19.83
  • CVCO $422.02
  • Analyst Decision
  • ADMA Strong Buy
  • CVCO Buy
  • Analyst Count
  • ADMA 4
  • CVCO 2
  • Target Price
  • ADMA $24.25
  • CVCO $522.50
  • AVG Volume (30 Days)
  • ADMA 3.4M
  • CVCO 94.5K
  • Earning Date
  • ADMA 05-07-2025
  • CVCO 05-22-2025
  • Dividend Yield
  • ADMA N/A
  • CVCO N/A
  • EPS Growth
  • ADMA N/A
  • CVCO 12.74
  • EPS
  • ADMA 0.84
  • CVCO 20.71
  • Revenue
  • ADMA $459,381,000.00
  • CVCO $2,015,458,000.00
  • Revenue This Year
  • ADMA $19.45
  • CVCO $8.86
  • Revenue Next Year
  • ADMA $28.10
  • CVCO $6.43
  • P/E Ratio
  • ADMA $23.74
  • CVCO $20.94
  • Revenue Growth
  • ADMA 62.23
  • CVCO 12.29
  • 52 Week Low
  • ADMA $9.40
  • CVCO $331.08
  • 52 Week High
  • ADMA $25.67
  • CVCO $549.99
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 46.14
  • CVCO 26.60
  • Support Level
  • ADMA $19.28
  • CVCO $427.97
  • Resistance Level
  • ADMA $20.14
  • CVCO $523.78
  • Average True Range (ATR)
  • ADMA 0.74
  • CVCO 18.17
  • MACD
  • ADMA -0.09
  • CVCO -10.91
  • Stochastic Oscillator
  • ADMA 55.14
  • CVCO 4.61

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

Share on Social Networks: